<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl4" position="float"><object-id pub-id-type="doi">10.7554/eLife.03680.026</object-id><label>Table 4.</label><caption><p>Final protein concentrations used for cryo-EM sample preparation</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03680.026">http://dx.doi.org/10.7554/eLife.03680.026</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th>Kinesin and nucleotide state</th><th>[MT] (&#956;M)</th><th>[Motor domain] (&#956;M)</th></tr></thead><tbody><tr><td>Kin3 MgADP</td><td>5</td><td>10</td></tr><tr><td>Kin3 NN</td><td>5</td><td>5</td></tr><tr><td>Kin3 Mg-AMPPNP</td><td>5</td><td>5</td></tr><tr><td>Kin3 Mg-ADP.AlFx</td><td>5</td><td>5</td></tr><tr><td>Kin1 NN</td><td>5</td><td>100</td></tr><tr><td>Kin1 Mg-AMPPNP</td><td>5</td><td>50</td></tr><tr><td>Kin1 Mg-ADP.AlFx</td><td>5</td><td>50</td></tr></tbody></table><table-wrap-foot><fn><p>Kin1 samples required higher concentrations than Kin3 to achieve good MT occupancy.</p></fn></table-wrap-foot></table-wrap>